NO900795L - Fremgangsmaate for fremstilling av nye 2-(1-piperazinyl)-4-fenylcykloalkanpyrimidinderivater. - Google Patents

Fremgangsmaate for fremstilling av nye 2-(1-piperazinyl)-4-fenylcykloalkanpyrimidinderivater.

Info

Publication number
NO900795L
NO900795L NO90900795A NO900795A NO900795L NO 900795 L NO900795 L NO 900795L NO 90900795 A NO90900795 A NO 90900795A NO 900795 A NO900795 A NO 900795A NO 900795 L NO900795 L NO 900795L
Authority
NO
Norway
Prior art keywords
phenylycylclanal
piperazinyl
procedure
preparation
new
Prior art date
Application number
NO90900795A
Other languages
English (en)
Other versions
NO900795D0 (no
Inventor
Katsuhiko Hino
Naoki Kai
Masato Sakamoto
Tatsuya Kon
Makoto Oka
Kiyoshi Furukawa
Yoshiaki Ochi
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of NO900795D0 publication Critical patent/NO900795D0/no
Publication of NO900795L publication Critical patent/NO900795L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO90900795A 1989-02-21 1990-02-20 Fremgangsmaate for fremstilling av nye 2-(1-piperazinyl)-4-fenylcykloalkanpyrimidinderivater. NO900795L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4072989 1989-02-21

Publications (2)

Publication Number Publication Date
NO900795D0 NO900795D0 (no) 1990-02-20
NO900795L true NO900795L (no) 1990-08-22

Family

ID=12588717

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900795A NO900795L (no) 1989-02-21 1990-02-20 Fremgangsmaate for fremstilling av nye 2-(1-piperazinyl)-4-fenylcykloalkanpyrimidinderivater.

Country Status (9)

Country Link
US (1) US5041443A (no)
EP (2) EP0384228A1 (no)
KR (1) KR910015562A (no)
AU (1) AU622976B2 (no)
CA (1) CA2010477A1 (no)
DD (1) DD297819A5 (no)
FI (1) FI900833A0 (no)
HU (1) HU204815B (no)
NO (1) NO900795L (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174591T1 (de) * 1993-09-15 1999-01-15 Merck Sharp & Dohme Kondensierte tricyclische heteroaromatische derivate als liganden des dopamin-rezeptor- subtyps
US20120121515A1 (en) 2009-03-13 2012-05-17 Lenny Dang Methods and compositions for cell-proliferation-related disorders
TWI598337B (zh) 2009-06-29 2017-09-11 阿吉歐斯製藥公司 治療化合物及組成物
CA2793836C (en) 2009-10-21 2020-03-24 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
EP3064595B1 (en) 2009-10-21 2019-02-27 Agios Pharmaceuticals, Inc. Methods for cell-proliferation-related disorders
KR101873543B1 (ko) 2011-05-03 2018-07-02 아지오스 파마슈티컬스 아이엔씨. 치료에 사용하기 위한 피루베이트 키나아제 활성제
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827170A (zh) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN115521264A (zh) 2012-01-06 2022-12-27 法国施维雅药厂 治疗活性化合物及其使用方法
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
WO2014062511A1 (en) 2012-10-15 2014-04-24 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
CN105593215B (zh) 2013-07-11 2019-01-15 安吉奥斯医药品有限公司 用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
KR20220070066A (ko) 2014-03-14 2022-05-27 아지오스 파마슈티컬스 아이엔씨. 치료적으로 활성인 화합물의 약제학적 조성물
MD3307271T2 (ro) 2015-06-11 2024-01-31 Agios Pharmaceuticals Inc Metode de utilizare a activatorilor de piruvat kinază
PL3362065T3 (pl) 2015-10-15 2024-09-16 Les Laboratoires Servier Terapia skojarzona zawierająca iwosidenib, cytarabinę i daunorubicynę lub idarubicynę do leczenia ostrej białaczki szpikowej
HRP20211790T1 (hr) 2015-10-15 2022-03-04 Les Laboratoires Servier Kombinirana terapija za liječenje maligniteta
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
EP4313967A1 (en) * 2021-03-29 2024-02-07 Gilead Sciences, Inc. Khk inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3305553A (en) * 1965-10-18 1967-02-21 Parke Davis & Co 2-aminoquinazoline derivatives
US3915976A (en) * 1972-09-01 1975-10-28 Sandoz Ag Substituted-4-phenyl-5h-cycloalkano(d)pyrimidines
US4133884A (en) * 1977-02-25 1979-01-09 Eli Lilly And Company Substituted pyrroloquinoxalinones and diones used in treating inflammation in warm blooded mammals
EP0022481A1 (en) * 1979-06-21 1981-01-21 Mitsubishi Yuka Pharmaceutical Co., Ltd. 5,6-Alkylenepyrimidine derivatives, processes for preparing the same and pharmaceutical compositions
DE3609596A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
JPS6442472A (en) * 1987-08-10 1989-02-14 Kanebo Ltd Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
EP0385237B1 (en) * 1989-03-03 1994-06-29 Dainippon Pharmaceutical Co., Ltd. 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
US5041443A (en) 1991-08-20
EP0384228A1 (en) 1990-08-29
HUT53098A (en) 1990-09-28
EP0484988A1 (en) 1992-05-13
AU4912290A (en) 1990-08-30
HU204815B (en) 1992-02-28
FI900833A0 (fi) 1990-02-20
HU900861D0 (en) 1990-05-28
NO900795D0 (no) 1990-02-20
AU622976B2 (en) 1992-04-30
KR910015562A (ko) 1991-09-30
CA2010477A1 (en) 1990-08-21
DD297819A5 (de) 1992-01-23

Similar Documents

Publication Publication Date Title
NO900795L (no) Fremgangsmaate for fremstilling av nye 2-(1-piperazinyl)-4-fenylcykloalkanpyrimidinderivater.
NO905255L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO900934L (no) Fremgangsmaate for fremstilling av nye derivater av 4-substituerte piperaziner.
NO862427D0 (no) Fremgangsmaate for fremstilling av nye piperazinderivater.
NO905008D0 (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO904059L (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO913612D0 (no) Fremgangsmaate for fremstilling av nye skualen-syntetase-inhibitorer.
NO902776L (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
NO892543L (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO901813D0 (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO903275D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO900074D0 (no) Fremgangsmaate for fremstilling av nye tetralinderivater.
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO892977L (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
NO904069L (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO891381D0 (no) Fremgangsmaate for fremstilling av nye fluorfosfonatnukleotidderivater.
NO872393L (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO912979L (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenederivater.
NO170278C (no) Analogifremgangsmaate for fremstilling av nye antimykotiskvirksomme 2-(tioalkylamino)etyl-1h-imidazolderivater
NO890644L (no) Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.